188 papers found
Refreshing results…
Characterization of T-cell responses against IκBα in cancer patients
T-cell dependent immunoselection
CD4 responses against IDO
Supplementary material 1
Additional file 3
Additional file 1
Additional file 2
A Promiscuous Survivin-Derived T-Cell Epitope Restricted to the HLA-A3 Super-Type Alleles
Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses
IFN-γ to improve immunotherapy for melanoma.
Adoptive cell therapy for melanoma patients using tumor-infiltrating lymphocytes, lymphodepleting chemotherapy, and low-dose interleukin-2.
Natural CD4+ T-Cell Responses against Indoleamine 2,3-Dioxygenase
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: Results from a phase II trial
The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase
Immunotherapy for metastatic colorectal cancer: Present status and new options
IFN-γ to improve immunotherapy for melanoma
Clinical & Cellular Influence of Metronomic Cyclophosphamide and Interleukine-2 alone or Combined on Blood Regulatory T Cells in Patients with Advanced Malignant Melanoma Treated with Dendritic Cell Vaccines
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures
HLA-A2-restricted survivin-derived T-cell responses
Missing publications? Read more about our data sources.